Extramammary Paget’s Disease: The Rare Skin Cancer You Might Mistake for Eczema

Key Facts on Extramammary Paget’s Disease (EMPD)

Usually, it begins quietly. An area of red, irritated skin that may be flaky or itchy. Many people think it looks like a small rash, possibly a fungal infection or a hint of eczema. The unique feature of Extramammary Paget’s Disease (EMPD) is that, despite its seeming simplicity, it conceals a much more complicated condition.

EMPD is more than just a rare type of skin cancer; it’s a condition that makes doctors consider more options. It usually affects older adults, usually those between the ages of 50 and 80, and is most common in places like the vulva, perineum, and scrotum. In some Asian populations, EMPD is significantly more common in men than in women, despite being diagnosed in women more often. This suggests that both genetic and environmental factors may be at work. Due to its rarity, it frequently goes months or even years without a proper diagnosis.

More patients have come forward in recent years to tell of their repeated medical visits, unsuccessful topical treatments, and persistent symptoms. Online, one woman talked about how a „rash that wouldn’t go away” ultimately resulted in an unanticipated cancer diagnosis. Her story, which has been repeated by others, highlights a crucial issue: EMPD initially appears to be harmless.

Primary and secondary are the two main categories of the condition. In primary EMPD, the apocrine sweat glands on the skin are where the disease first appears. Internal cancers that spread toward the skin’s surface, usually affecting the bladder, prostate, rectum, or cervix, are the cause of secondary EMPD. Because of this correlation, a diagnosis of EMPD frequently results in a comprehensive series of imaging tests and screenings.

The slow progression and silent tissue invasion of EMPD are what make it so concerning. Lesions may begin as red, crusty plaques with distinct edges. They may develop into nodules or ulcerate over time. While some patients report tenderness or swelling, others describe a burning sensation. Because the condition usually occurs in areas of the skin that are normally covered by underwear, some doctors have named its pattern “underpants-shaped erythema”—a term that emphasizes the condition’s location and severity.

The growing use of Mohs micrographic surgery is one of the more promising developments in the treatment of EMPD. Surgeons can use this technique to remove the cancer layer by layer while instantly examining the margins under a microscope. Mohs provides a method for maintaining healthy tissue while guaranteeing complete removal, especially in delicate areas. According to studies, it is much more successful than traditional excision, with a lower chance of recurrence and a quicker recovery period.

However, EMPD has a reputation for returning. Patients may have a local recurrence even after surgery. The microscopic dissemination of Paget cells outside of the visible lesion is partially to blame for this. Clean surgical margins are extremely challenging because these cells can infiltrate hair follicles and ducts and carry distinctive markers like cytokeratins and GCDFP-15.

Doctors may use topical treatments or radiation therapy in certain situations, particularly when surgery is not an option. Topical immune-response modifiers such as imiquimod have demonstrated promise in superficial lesions. Despite ongoing research, preliminary findings are incredibly promising. A patient who used topical imiquimod to achieve full remission and completely avoid invasive surgery was the subject of one case study.

Over the past ten years, there has been a noticeable improvement in medical circles’ awareness. There are now more precise guidelines for dermatologists on when to suspect EMPD, and interdisciplinary cooperation with gastroenterologists, gynecologists, and oncologists is growing in popularity. This results in quicker diagnosis and more focused treatment for patients.

However, a startling lack of public awareness still exists. Melanoma and other skin, lung, and breast cancers are frequently the focus of high-profile cancer campaigns. EMPD rarely receives attention, even though it is directly linked to internal malignancies. This quietness adds to a lack of urgency and delays in diagnosis. Public education could drastically cut down on late-stage presentations, particularly among general practitioners and older adults.

It’s also important to consider EMPD’s emotional toll. Some patients put off getting treatment because they feel uncomfortable or embarrassed because it usually affects private areas. There may be severe repercussions from this hesitation. It is necessary to normalize rather than stigmatize discussions about genital or perianal symptoms. As conversations about prostate or cervical cancer have become more transparent, so too should EMPD.

Fortunately, non-invasive EMPD has a very promising prognosis. Five-year survival rates range from 75% to 95% with early diagnosis and appropriate treatment. Although the prognosis for invasive cases—or those associated with other cancers—is more cautious, they can still be controlled with all-encompassing care.

In the future, scientists are investigating how genetics could contribute to more individualized treatment for EMPD. Genes like TP53 and ERBB2, which are frequently found to have mutations in other aggressive cancers, are currently being researched as possible targets for future treatments. For rare cancers like EMPD, personalized medicine—which matches a patient’s treatment to their genetic profile—holds particular promise.

Working together, dermatologists and oncologists benefit the healthcare system as well. EMPD is „the skin’s whisper that something deeper might be wrong,” according to one doctor. If you hear that whisper in time, it could save your life. After treatment, follow-ups must be thorough and prolonged. Vigilance is crucial, as some patients have reported recurrences over ten years later.

Even though EMPD is still rare, its wider significance is very evident. It serves as a reminder to both patients and clinicians that our skin frequently betrays our inner selves. When we approach it with interest and consideration, we not only deal with the obvious but occasionally reveal what might have been developing covertly.